Morgan Stanley Maintains Overweight on RH, Lowers Price Target to $240

Benzinga Newsdesk www.benzinga.com Negative 82.2%

Neg 82.2% Neu 0% Pos 0%

Morgan Stanley analyst Simeon Gutman maintains RH (NYSE:RH) with a Overweight and lowers the price target from $275 to $240.